Mitchells & Butlers PLC
DUS:MABB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mitchells & Butlers PLC
DUS:MABB
|
UK |
|
I
|
Iovance Biotherapeutics Inc
LSE:0JDK
|
US |
|
E
|
Energy Resources Of Australia Ltd
XMUN:EJ7
|
AU |
Wall St Price Targets
MABB Price Targets Summary
Mitchells & Butlers PLC
According to Wall Street analysts, the average 1-year price target for MABB is 4.06 EUR with a low forecast of 3.67 EUR and a high forecast of 4.58 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MABB's stock price target?
Price Target
4.06
EUR
According to Wall Street analysts, the average 1-year price target for MABB is 4.06 EUR with a low forecast of 3.67 EUR and a high forecast of 4.58 EUR.
What is the Revenue forecast for Mitchells & Butlers PLC?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Mitchells & Butlers PLC?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 4%.
What is the Net Income forecast for Mitchells & Butlers PLC?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 9%.
